Stock Market News

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

wcc wcc
Jul 11, 2026 - 14:05
0 1
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.

Previous Article

'Funflation' hits home: Why staying in isn't the cost-saver it used to be

Next Article

Burnout, frustration and heartbreak: Amazon layoffs take their toll in satura...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0
wcc
wcc

Related Posts

Big bank profit engines expected to roar into earnings as Main Street keeps spending

Big bank profit engines expected to roar into earnin...

wcc
Jul 11, 2026
0
1
Jim Cramer Is Impressed By Catch Up In The Boeing Company (BA)’s Shares

Jim Cramer Is Impressed By Catch Up In The Boeing Co...

wcc
Jul 11, 2026
0
1

Burnout, frustration and heartbreak: Amazon layoffs ...

wcc
Jul 11, 2026
0
1
Honeywell Aerospace Inc. (HONA) Is Starting Its Take Off, Says Jim Cramer

Honeywell Aerospace Inc. (HONA) Is Starting Its Take...

wcc
Jul 11, 2026
0
1
Broadcom Inc. (AVGO) Is Going To Come Back, Says Jim Cramer

Broadcom Inc. (AVGO) Is Going To Come Back, Says Jim...

wcc
Jul 11, 2026
0
1
Jim Cramer Left Enthused By Lam Research Corporation (LRCX)’s Shares

Jim Cramer Left Enthused By Lam Research Corporation...

wcc
Jul 11, 2026
0
1

Comments (0)

User